Kolmogorov-Smirnov statistical test for analysis of ZAP-70 expression in B-CLL, compared with quantitative PCR and IgVH mutation status

被引:16
作者
Van Bockstaele, Femke
Janssens, Ann
Piette, Anne
Callewaert, Filip
Pede, Valerie
Offner, Fritz
Verhasselt, Bruno
Philippe, Jan
机构
[1] Univ Ghent, Dept Clin Chem, B-9000 Ghent, Belgium
[2] Univ Ghent, Dept Internal Med, B-9000 Ghent, Belgium
关键词
ZAP-70; B-CLL; Kolmogorov-Smirnov statistics; immunoglobulin heavy-chain variable region; mutation qPCR; flow cytometry;
D O I
10.1002/cyto.b.20122
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: ZAP-70 has been proposed as a surrogate marker for immunoglobulin heavy-chain variable region (IgV(H)) mutation status, which is known as a prognostic marker in B-cell chronic lymphocytic leukemia (CLL). The flow cytometric analysis of ZAP-70 suffers from difficulties in standardization and interpretation. We applied the Kolmogorov-Smirnov (KS) statistical test to make analysis more straightforward. Methods: We examined ZAP-70 expression by flow cytometry in 53 patients with CLL. Analysis was performed as initially described by Crespo et al. (New England J Med 2003; 348:1764-1775) and alternatively by application of the KS statistical test comparing T cells with B cells. Receiver-operating-characteristics (ROC)-curve analyses were performed to determine the optimal cut-off values for ZAP-70 measured by the two approaches. ZAP-70 protein expression was compared with ZAP-70 mRNA expression measured by a quantitative PCR (qPCR) and with the IgV(H) mutation status. Results: Both flow cytometric analyses correlated well with the molecular technique and proved to be of equal value in predicting the IgV(H) mutation status. Applying the KS test is reproducible, simple, straightforward, and overcomes a number of difficulties encountered in the Crespo-method. Conclusions: The KS statistical test is an essential part of the software delivered with modern routine analytical flow cytometers and is well suited for analysis of ZAP-70 expression in CLL. (c) 2006 International Society for Analytical Cytology.
引用
收藏
页码:302 / 308
页数:7
相关论文
共 30 条
[1]  
AUBIN J, 1995, LEUKEMIA, V9, P471
[2]   Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program [J].
Beillard, E ;
Pallisgaard, N ;
van der Velden, VHJ ;
Bi, W ;
Dee, R ;
van der Schoot, E ;
Delabesse, E ;
Macintyre, E ;
Gottardi, E ;
Saglio, G ;
Watzinger, F ;
Lion, T ;
van Dongen, JJM ;
Hokland, P ;
Gabert, J .
LEUKEMIA, 2003, 17 (12) :2474-2486
[3]  
BINET JL, 1981, CANCER-AM CANCER SOC, V48, P198, DOI 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO
[4]  
2-V
[5]   USE OF FAMILY SPECIFIC LEADER REGION PRIMERS FOR PCR AMPLIFICATION OF THE HUMAN HEAVY-CHAIN VARIABLE REGION GENE REPERTOIRE [J].
CAMPBELL, MJ ;
ZELENETZ, AD ;
LEVY, S ;
LEVY, R .
MOLECULAR IMMUNOLOGY, 1992, 29 (02) :193-203
[6]  
Chen JC, 2000, CYTOMETRY, V42, P239, DOI 10.1002/1097-0320(20000815)42:4<239::AID-CYTO4>3.0.CO
[7]  
2-Z
[8]   Macrophage mannose receptor in chronic sinus disease [J].
Claeys, S ;
De Belder, T ;
Holtappels, G ;
Gevaert, P ;
Verhasselt, B ;
Van Cauwenberge, P ;
Bachert, C .
ALLERGY, 2004, 59 (06) :606-612
[9]   ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia [J].
Crespo, M ;
Bosch, F ;
Villamor, N ;
Bellosillo, B ;
Colomer, D ;
Rozman, M ;
Marcé, S ;
López-Guillermo, A ;
Campo, E ;
Montserrat, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (18) :1764-1775
[10]   Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia [J].
Damle, RN ;
Wasil, T ;
Fais, F ;
Ghiotto, F ;
Valetto, A ;
Allen, SL ;
Buchbinder, A ;
Budman, D ;
Dittmar, K ;
Kolitz, J ;
Lichtman, SM ;
Schulman, P ;
Vinciguerra, VP ;
Rai, KR ;
Ferrarini, M ;
Chiorazzi, N .
BLOOD, 1999, 94 (06) :1840-1847